Caricamento...
In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine
Studies were performed in eight healthy extensive metabolizers of mephenytoin and debrisoquine to determine the effect of fluvoxamine on the activities of S-mephenytoin 4′-hydroxylase (CYP2C19) and metoprolol α-hydroxylase (CYP2D6). Therapeutic dosing with fluvoxamine (100 mg day(−1)) for 2 weeks ca...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
1996
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2042705/ https://ncbi.nlm.nih.gov/pubmed/8904628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1996.45319.x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|